Close

This is a StreetInsider.com Premium Only Page

Please sign-up to enjoy all the benefits of StreetInsider.com Premium or log-in if you're already a member.

Send to a Friend Font Size: Increase Decrease

Back to DCPH Stock Lookup

(DCPH) – Globe Newswire

Mar 31, 2021 04:57 AM China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)
Mar 31, 2021 04:57 AM China NMPA Approves QINLOCK® (Ripretinib) for Treatment of Advanced Gastrointestinal Stromal Tumors (GIST)
Jul 20, 2020 07:30 AM China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor
Jul 20, 2020 07:30 AM China NMPA Accepts NDA Submission of Ripretinib for Advanced Gastrointestinal Stromal Tumor

Back to DCPH Stock Lookup